** Shares of India's Zydus Lifesciences ZYDU.NS jump to 6.15% to 1081.55 rupees
** Co's Q4 consol net profit rose ~8.7% y/y to 12.73 billion rupees ($131.87 million)
** Total revenue from ops rose 16.2%, driven by growth in consumer products, medical technologies segments
** Dolat Capital lifts PT by 96 rupees to 1,182 rupees; raises FY27 and FY28 earnings estimates by 8.6% and 8.9%, respectively, on higher sales, margins
** JPMorgan cuts PT by 10 rupees to 1,050 rupees; raises FY27 earnings estimates by 10% on strong guidance, sees ~15% core EPS CAGR over the next two years
** Jefferies raises FY28 EPS estimates by 14%, citing new product launches
** ZYDU shares closed up 2.8% on Tuesday after results
** YTD, stock up ~11.5%
($1 = 96.5325 Indian rupees)
(Reporting by Bipasha Dey in Bengaluru)
((Bipasha.Dey@thomsonreuters.com;))